Ribonucleases and host defense: identification, localization and gene expression in adherent monocytes in vitro  by Egesten, Arne et al.
 .Biochimica et Biophysica Acta 1358 1997 255–260
Ribonucleases and host defense: identification, localization and gene
expression in adherent monocytes in vitro
Arne Egesten 1, Kimberly D. Dyer, Dean Batten 2, Joseph B. Domachowske 3,
Helene F. Rosenberg )
Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892,
USA
Received 4 March 1997; accepted 9 May 1997
Abstract
Several ribonucleases of the RNase A family function as antibacterial, anti-parasitic, and anti-viral agents. In this work,
we have shown that mRNAs encoding five of the six known human ribonucleases of the RNase A family are expressed in
cultured human monocytes, and that ribonucleases are released by adherent monocytes in culture. Using a polyclonal
antiserum prepared against recombinant protein, we have detected one of these ribonucleases, RNase 4, in lysates of normal
human peripheral blood monocytes, but not granulocytes or lymphocytes, by Western blotting. Subcellular localization by
immunoelectron microscopy demonstrated the presence of RNase 4 in the cytoplasmic granules of isolated monocytes.
Interestingly, mRNA encoding RNase 4 could not be detected in freshly isolated monocytes, emerging only after 16 h in
culture, suggesting the possibility of de novo protein synthesis in association with monocyte differentiation. q 1997 Elsevier
Science B.V.
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1. Introduction
The RNase A family of ribonucleases, whose
w xmembers include pancreatic ribonuclease 1 , the
w xeosinophil-derived neurotoxin 2,3 , eosinophil
w x w xcationic protein 4,5 , angiogenin 6,7 , and the re-
w xcently identified ribonuclease k6 8 , are a group of
proteins with shared primary and secondary structure
that support a variety of divergent biologic activities.
There is evidence linking several of these ribonucle-
ases to roles in host defense. The eosinophil ribo-
nuclease ECP is the best characterized in this regard,
as it is secreted from activated eosinophils in vivo,
and functions as an effective anti-bacterial and anti-
w xparasitic agent in in vitro experimental systems 9,10 .
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Although its physiologic function has not yet been
identified, EDN is also secreted from activated
eosinophils, and mRNA encoding both EDN and
RNase k6 were detected in peripheral blood neu-
w x w xtrophils 2,8 . Recently, Youle and colleagues 11,12
have described the antiviral properties of the amphib-
ian ribonuclease, onconase.
Human RNase 4 is a 16-kDa, non-glycosylated
secretory protein that was first isolated from condi-
tioned medium from the HT-29 adenocarcinoma cell
w xline by Shapiro and colleagues 13 . The complete
w xamino acid sequence was determined 14 and a
cDNA sequence encoding human RNase 4 was iso-
w xlated 15 . Although the 2.0-kb transcript encoding
w xRNase 4 was detected in all human tissues tested 8 ,
 .the individual cell type or types capable of produc-
ing this protein had not been identified.
In the present study, we have detected transcripts
encoding five of the six known human ribonucleases
in cultures of peripheral blood monocytes, and we
demonstrate the presence of RNase 4 in the cytoplas-
mic granules. Although ribonuclease activity has been
w xassociated with rodent monocyte populations 17,18 ,
the source of this activity in human monocytes had
not been identified or characterized until now. In
addition, we demonstrate that the expression of the
gene encoding RNase 4 is amplified in cultured,
adherent monocytes, suggesting the possibility of de
novo protein synthesis.
2. Materials and methods
2.1. Preparation of rabbit polyclonal antiserum to
RNase 4
w xThe complete coding sequence of RNase 4 16
was PCR-amplified with primer-encoded restriction
sites to facilitate subcloning into the pGEX-3X ex-
 .pression vector Pharmacia, Piscataway, NJ . Large
scale cultures were prepared and protein isolated by
 .glutathione–Sepharose chromatography Pharmacia
w xas described 19 . The glutathione-S-transferase
 .GST –RNase 4 fusion protein was purified by
preparative acrylamide gel electrophoresis, and the
acrylamide slice containing ;150-mg recombinant
protein was homogenized, combined with complete
 .  .first injection or incomplete subsequent injections
Freund’s adjuvant prior to immunization. The har-
vested serum was precleared against a GST-contain-
ing bacterial lysate prior to use to improve speci-
ficity.
2.2. Isolation of normal human monocytes
Mononuclear leukocytes were harvested by
apheresis of normal donors Department of Transfu-
.sion Medicine, NIH or by phlebotomy of normal
volunteers followed by Ficoll-Hypaque density sepa-
ration. Washed mononuclear cells were resuspended
in RPMI 1640 containing 10% heat-inactivated fetal
calf serum Hyclone Laboratories, Inc., Gaithersburg,
. MD , 2 mM L-glutamine Quality Biologicals, Inc.,
.Gaithersburg, MD and 100 unitsrml penicillin q100
 . 8mgrml streptomycin Quality Biologicals at 10
cellsrml. The cells were incubated at 378C with 5%
carbon dioxide in a humidified incubator until har-
vested. At the time-points indicated, adherent cells
were harvested, and cell count and viability were
 .determined )98% with Trypan blue .
2.3. Isolation of granulocytes and lymphocytes
Blood from healthy volunteers was drawn into
heparinized syringes, and separated by Ficoll-Hy-
w xpaque gradient centrifugation as described 20 .
Mononuclear cells at the interface were collected, and
permitted to adhere to plastic tissue culture plates as
described above for 1.5 h; the lymphocytes remaining
in the supernatant were collected and lysed in 1%
Triton 50 mM Tris, 150 mM NaCl, 0.02% sodium
azide, 100 mgrml phenylmethylsulfonylfluoride, and
.1% Triton X-100 . The granulocytes and red blood
cells at the bottom of the Ficoll-Hypaque gradient
were also collected; the red blood cells were lysed
 .ACK lysing buffer, Biowhittaker, Walkersville, MD ,
and the granulocytes remaining were lysed in the 1%
Triton buffer at a concentration 108 cellsrml.
2.4. Western blotting
Triton lysates were subjected to polyacrylamide
 .gel electrophoresis SDS–PAGE on 14% Tris–
glycine gels Novel Experimental Technologies, San
.Diego, CA followed by Western blotting using stan-
w xdard procedures 19,21 ; the primary antibody was
used at a 1:100 dilution, followed by a 1:1000 dilu-
 .tion of goat anti-rabbit IgG Biorad, Richmond, CA .
( )A. Egesten et al.rBiochimica et Biophysica Acta 1358 1997 255–260 257
2.5. Immunoelectron microscopy
Cells collected as described above were fixed in
3% formaldehyde and 1% glutaraldehyde in PBS for
1 h followed by rinsing in PBS, dehydration in
graded ethanol, and subsequent embedding in LR
White. Ultrathin sections mounted on Formvar-coated
grids were prepared. During incubations, the grids
were floated on the surface of droplets. To block
non-specific binding, the sections were incubated with
PBS containing 0.5% bovine serum albumin and
 .0.05% Tween 20 PBS-BSAT for 1 h followed by
incubation for 1 h at room temperature with specific
rabbit anti-serum to RNase 4 at a dilution of 1:100 in
PBS-BSAT. After extensive rinsing in PBS-BSAT,
sections were incubated with protein A-gold complex
 .Amersham, Arlington Heights, IL with a gold parti-
cle size of 10 nm for 1 h at room temperature
followed by rinsing with distilled water, and staining
with 2% uranyl-acetate for 10 min and lead citrate for
1 min. Examination was performed in a Zeiss EM 10
electron microscope.
2.6. Re˝erse transcriptase–polymerase chain reac-
( )tion RT–PCR
Total RNA extracted with RNAzol TelTest,
.Friendship, TX was subjected to RT–PCR as de-
w xscribed 22 . First and second cDNA strands were
synthesized from total RNA from 106 cells with a
cDNA synthesis kit Boehringer Mannheim, Indi-
.anapolis, IN as per manufacturer’s instructions. The
cDNA synthesized was subjected to PCR 35 cycles,
.50 ml reaction volume with gene-specific primers, as
follows: Human pancreatic ribonuclease HPR, RNase
. X1, Genbank aX62946 5 GAA TCC CGG GCC
 . XAAG AAA TTC bp 24–44 and 3 GTG TCT CTC
 .CTT CGG GCT GGT 335–315 ; eosinophil-derived
 .neurotoxin EDN, RNase 2 and eosinophil cationic
 . w xprotein ECP, RNase as described 23 ; RNase 4
 . XGenbank accession aU37931 5 ATG GCT CTG
 . XCAG AGG ACC CAT bp 28–48 and 3 AAC CAC
 .TCG CGA TAA TCC CTA bp 483–503 ; angio-
 . Xgenin ANG, RNase 5, Genbank a M11567 5 CGG
GGC CTG ACC TCA CCC TGC AAA and 3X TCT
GAA CCC CGC TGT GGC TCG GTA; RNase k6 as
w x  . Xdescribed 8 ; actin Genbank aM10277 5 GTG
 .GGG CGC CCC AGG CAC CA bp 1195–1214 and
X 3 CTC CTT AAT GTC ACG CAC GAT TTC bp
.2284–2307 . The PCR products were subject to
agarose gel electrophoresis, and products of the antic-
ipated size were identified and confirmed by sequenc-
ing or by Southern blotting with 32P-radio-labeled
probes derived from the complete open reading
frames.
2.7. Ribonuclease assay
Supernatants from adherent cell cultures were har-
vested at 4 and 24 h after monocyte isolation. The
ribonuclease activity present in 10-ml samples was
determined in triplicate with 50 mgrml tRNA sub-
w xstrate as described 24 .
3. Results
3.1. Expression of genes encoding human ribonucle-
ases by re˝erse transcriptase–polymerase chain reac-
( )tion RT–PCR
Gel electrophoresis of the products of RT–PCR
derived from mRNA from adherent human mono-
Fig. 1. Acrylamide gel electrophoresis of the products of reverse
 .transcriptase–polymerase chain reaction RT–PCR with mono-
cyte RNA as template. Primers were designed to amplify human
 .pancreatic ribonuclease HPR, RNase 1, lane 1 , eosinophil-de-
 .rived neurotoxin EDN, RNase 2, lane 2 , eosinophil cationic
 .  .protein ECP, RNase 3, lane 3 , RNase 4 R4, lane 4 , angiogenin
 .  .ANG, RNase 5, lane 5 , and RNase k6 RK6, lane 6 , with the
products of PCR reaction performed in the absence of template
RNA included in lanes 7–12, respectively. EDN and ECP se-
quences amplified from RNA isolated from the eosinophilic
w xHL-60 clone 15 cell line 26 , serving as positive controls, are
shown in lanes 13 and 14, respectively.
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 .cytes 3 day cultures is shown in Fig. 1. Messenger
 .RNAs encoding pancreatic ribonuclease RNase 1 ,
RNase 4, angiogenin, and RNase k6 were readily
detected by this method; a minor band representing
EDN was also present. Messenger RNA encoding
ECP was not detected. Interestingly, mRNAs encod-
ing the four major ribonucleases found in monocytes
can be detected in a wide variety of cells and cell
lines, while EDN and ECP appear to have a more
restricted pattern of expression Rosenberg, unpub-
.lished results .
3.2. Detection of RNase 4 in peripheral blood mono-
cytes
The specificity of the pre-cleared polyclonal rabbit
antiserum raised against the GST–RNase 4 fusion
protein is shown in Fig. 2A. The antiserum used at a
 .1:100 dilution does not detect GST 26 kDa , but
 .specifically detects GST–RNase 4 42 kDa on West-
ern blots. This technique was used to identify im-
munoreactive RNase 4 in subsets of isolated periph-
 .eral blood leukocytes Fig. 2B . RNase 4 was de-
tected in lysates prepared from isolated monocytes,
but not in lysates from lymphocytes or granulocytes.
The observed mobility is consistent with the molecu-
w xlar weight of RNase 4 reported previously 13,14 and
w xpredicted by molecular cloning 15,16 . The absence
of higher molecular weight, glycosylated forms of
RNase 4 is consistent with the absence of potential
sites for N-linked glycosylation within the amino acid
sequence of this protein. Immunoreactive RNase 4
was detected on Western blots containing lysates of
cultured adherent monocytes harvested at the time
 .points indicated Fig. 2D . The intensity of the im-
munoreactive band decreased with time in culture,
similar to that observed for the monocyte granule
w xprotein myeloperoxidase 25 . Although not detected
on Western blots of concentrated culture supernatants
 .data not shown , RNase 4 may be among the ribonu-
 .Fig. 2. A Western blot demonstrating specific detection of the recombinant GST-RNase 4 antigen with the precleared polyclonal
 . antiserum. Lane 1, bacterial lystate with recombinant GST 26 kDa ; lane 2, bacterial lysate with recombinant GST-RNase 4 42 kDa, at
.  .  .  .arrow and a 30-kDa degradation product. B Western blot of leukocyte lysates probed as in A . Lane 1, granulocytes g ; lane 2,
 .  7 .  8 .lymphocytes l ; lane 3, monocytes m; 10 cells ; lane 4, monocytes m; 10 cells ; arrow indicates mobility of immunoreactive RNase 4.
 .C Electron micrograph of an isolated monocyte demonstrating subcellular localization of RNase 4 by immunogold labelling.
 .  .Cytoplasmic granule is indicated by the arrow gr ; nucleus is labelled ‘n’. Magnification =10 000. D Western blot of monocyte lysates
 .  .  .probed with the polyclonal anti-RNase 4 antiserum. Adherent monocytes were harvested after 1.5 h lane 1 , 4 h lane 2 , 16 h lane 3
 .and 24 h lane 4 in culture. Arrow indicates the mobility of immunoreactive RNase 4.
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cleases secreted from adherent monocytes during this
 .time period see below .
3.3. Ultrastructural localization of RNase 4 in mono-
cytes
Ultrathin sections of monocytes processed for elec-
tron microscopy were incubated with rabbit antibody
to RNase 4 and visualized by protein A–gold conju-
gate. RNase 4 was detected in cytoplasmic granules
 .of monocytes Fig. 2C . There was no background
staining outside the cell.
3.4. Determination of RNase 4 gene expression by
RT–PCR
RT–PCR was used to detect mRNA encoding
RNase 4 in cultures of adherent monocytes at various
time points. No mRNA encoding RNase 4 could be
detected in the adherent cell cultures at the earliest
 .time points 1.5 h, 4 h ; RNase 4 mRNA was first
detected at 16 h, and remained detectable at the 24-h
 .time point Fig. 3 .
3.5. Ribonuclease acti˝ity released by adherent
monocyte cultures
The enzymatic activity of ribonucleases released
by adherent monocytes in culture is shown in Fig. 4.
Ribonuclease secretion is clearly ongoing during this
 .  .Fig. 3. A Reverse transcriptase–PCR RT–PCR detection of a
475-bp fragment of the RNase 4 transcript from RNA from
 .  .adherent monocytes harvested after 1.5 h lane 1 , 4 h lane 2 ,
 .  .  .16 h lane 3 , and 24 h lane 4 in culture. B RT–PCR detection
of a 514-bp fragment of the human b-actin transcript; lanes
 .defined in A .
Fig. 4. Ribonuclease activity detected in supenatants from adher-
ent monocytes harvested after 4 and 24 h in culture. The concen-
 .trations of solubilized ribonucleotides nmolrml derived from
50 mgrml yeast tRNA substrate were measured spectrophoto-
w xmetrically as described 24 . Points shown represent averages of
triplicate samples corrected for the background rate serum ri-
.bonucleases present in the culture medium .
period of time, with a two-fold increase in activity
observed between 4 and 24 h.
4. Discussion
In this study, we demonstrated that human mono-
cytes express mRNA encoding five ribonucleases of
 .the RNase A family, and that ribonuclease s are
secreted from these adherent cells in culture in vitro.
We have shown that one of these ribonucleases,
RNase 4, is a component of the cytoplasmic granules
of human peripheral blood monocytes and that there
is an unexpected up-regulation of RNase 4 mRNA
during the earliest stages of monocyte differentiation
in vitro.
Although specific ribonucleases have been identi-
fied as secretory effectors of human granulocytes
w x5,9,10 , RNase 4 is the first of this family of proteins
to be identified as a component of normal human
monocytes. Furthermore, the subcellular localization
of RNase 4 to a cytoplasmic granule compartment
provides clues toward the determination of its func-
tion. While it is possible that secreted RNase 4 exists
simply to degrade polymeric RNA released from
target pathogens, its distinct substrate preference
 X w x.cleaving at the 3 side of uridine residues 13 and
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its limited distribution among peripheral blood leuko-
cytes suggests a role in functions that are unique to
the monocyte-macrophage lineage.
While it would not be surprising to find that
adherence, as the first step in conversion to the
macrophage phenotype, signals the release of pre-
formed RNase 4 from the cytoplasmic granules, we
were surprised to find that adherence was associated
with an ‘up-regulation’ of expression of the RNase 4
gene. Future studies will permit us to determine the
fate of these transcripts. We are particularly inter-
ested in whether these transcripts represent a source
of a ‘second wave’ of RNase 4 synthesis, which
might explain why immunoreactive RNase 4 did not
disappear completely in the adherent cell cultures.
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